logo
Highlights from the 2nd Annual Future of Supportive Therapy in Oncology
Control of Chemotherapy-Induced Emesis with 5-Hydroxytryptamine-3 Antagonists
Impact of Correction of Anemia on Clinical Outcome in Patients with Cancer
The Management of Bone Loss in Patients with Breast or Prostate Cancer
Strategies for Pain Management
Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist
A Comparison of Radiation Therapy Outcomes of Bone Metastases Employing International Consensus Endpoints and Traditional Endpoints
Quality of Life after Local External Beam Radiation Therapy for Symptomatic Bone Metastases
What Is the Evidence for Implantable Drug Delivery Systems for Refractory Cancer Pain?